You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 268 No. 23, December 16, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Confidential HIV Testing and Condom Promotion in Africa

Impact on HIV and Gonorrhea Rates

Susan Allen, MD, DTM&H; Antoine Serufilira, MD; Joseph Bogaerts, MD; Philippe Van de Perre, MD; Francois Nsengumuremyi, MD; Christina Lindan, MD; Michel Carael, PhD; William Wolf; Thomas Coates, PhD; Stephen Hulley, MD, MPH

JAMA. 1992;268(23):3338-3343.


Abstract

Objective.
—We evaluated the impact of human immunodeficiency virus (HIV) testing and counseling on self-reported condom and spermicide use and on corresponding HIV seroconversion and gonorrhea rates in urban Rwandan women.

Design.
—Prospective cohort study with 2 years of follow-up, comparison of outcome variables before and after an intervention, and condom use measured in a control group that did not receive the intervention.

Setting.
—Outpatient research clinic in Kigali, the capital of Rwanda.

Participants.
—One thousand four hundred fifty-eight childbearing women, 32% of whom were infected with HIV, were enrolled in a prospective study in 1988, and followed at 3- to 6-month intervals for 2 years. Follow-up was available for 95% of subjects at year 1 and 92% at year 2.

Interventions.
—An acquired immunodeficiency syndrome (AIDS) educational videotape, HIV testing and counseling, and free condoms and spermicide were provided to all participants and interested sexual partners.

Main Outcome Measures.
—Self-report of compliance with condom-spermicide use and observed incidence of HIV and gonorrhea.

Results.
—Only 7% of the women reported ever trying condoms before the intervention, but 22% reported condom use with good compliance 1 year later. Women who were HIV-positive were more likely to adopt condom use than HIV-negative women (36% vs 16%; P<.05). Independent predictors of condom use, both in HIV-positive and in HIV-negative women, included HIV testing and counseling of the male partner, having a nonmonogamous relationship, and believing condoms were not dangerous. Human immunodeficiency virus seroconversion rates decreased significantly (from 4.1 to 1.8 per 100 person-years; P<.04) in women whose partners were tested and counseled. The prevalence of gonorrhea decreased substantially (13% to 6%; P<.05) among HIV-positive women, with the greatest reduction among condom users (16% to 4%; P<.05).

Conclusion.
—A confidential HIV testing and counseling program was associated with increased use of condoms and reduced rates of gonorrhea and HIV in urban Rwandan women. The lack of risk reduction in HIV-negative women whose partner's serostatus was unknown was of concern. Interventions that promote HIV testing and counseling for both members of a couple should be considered in other high-prevalence areas.

(JAMA. 1992;268:3338-3343)



Author Affiliations

From the Department of Pathology (Dr Allen), the Division of Clinical Epidemiology, Department of Epidemiology and Biostatistics (Drs Allen, Lindan, Coates, Hulley, and Mr Wolf), and the Center for AIDS Prevention Studies, Division of General Internal Medicine, Department of Medicine (Drs Allen, Lindan, Coates, and Hulley, and Mr Wolf), University of California, San Francisco; Projet San Francisco (Drs Allen, Serufilira, and Nsengumuremyi) and the National AIDS Control Program (Dr Van de Perre), Ministry of Health, Kigali, Rwanda; Belgian-Rwandan Cooperation, Kigali, Rwanda (Drs Bogaerts and Van de Perre); and the Global Programme on AIDS, World Health Organization, Geneva, Switzerland (Dr Carael).


Footnotes

Reprint requests to Center for AIDS Prevention Studies, University of California, San Francisco, 74 New Montgomery 600, San Francisco, CA 94105 (Dr Allen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Addressing the Unique Needs of African American Women in HIV Prevention
El-Bassel et al.
Am. J. Public Health 2009;99:996-1001.
ABSTRACT | FULL TEXT  

Behaviour change in clients of health centre-based voluntary HIV counselling and testing services in Kenya
Arthur et al.
Sex. Transm. Infect. 2007;83:541-546.
ABSTRACT | FULL TEXT  

Scaling Up HIV Voluntary Counseling and Testing in Africa: What Can Evaluation Studies Tell Us About Potential Prevention Impacts?
Glick
Eval Rev 2005;29:331-357.
ABSTRACT  

The Social Epidemiology of Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Poundstone et al.
Epidemiol Rev 2004;26:22-35.
FULL TEXT  

HIV Infection and Pregnancy Status Among Adults Attending Voluntary Counseling and Testing in 2 Developing Countries
Forsyth et al.
Am. J. Public Health 2002;92:1795-1800.
ABSTRACT | FULL TEXT  

Quantitative process evaluation of a community-based HIV/AIDS behavioural intervention in rural Uganda
Kinsman et al.
Health Educ Res 2002;17:253-265.
ABSTRACT | FULL TEXT  

How can psychological theory help to promote condom use in sub-Saharan African developing countries?
Campbell
The Journal of the Royal Society for the Promotion of Health 1997;117:186-191.
ABSTRACT  

Psychological and Behavioral Factors Predicting Attendance at a Community-based HIV Prevention Intervention
Thompson et al.
J Health Psychol 1997;2:75-84.
ABSTRACT  

Risk Factors for HIV-1 Seroconversion Among Young Men in Northern Thailand
Celentano et al.
JAMA 1996;275:122-127.
ABSTRACT  

Prevention of HIV Infection: Looking Back, Looking Ahead
Stryker et al.
JAMA 1995;273:1143-1148.
ABSTRACT  

The Public Health Implications of AIDS Research in Africa
De Cock et al.
JAMA 1994;272:481-486.
ABSTRACT  

Ethical, Behavioral, and Social Aspects of HIV Vaccine Trials in Developing Countries
Lurie et al.
JAMA 1994;271:295-301.
ABSTRACT  

AIDS in the Global Village: Why US Physicians Should Care About HIV Outside the United States
Berkley
JAMA 1992;268:3368-3369.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.